Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 177 results for "orchid pharma"

Top nine cos add over Rs 68,000 crore in market cap
India Infoline

Buy Orchid Pharma with a target of Rs 48: Mitesh Thacker

In a chat with , Mitesh Thacker of miteshthacker.com, says buy Orchid Pharma Ltd with a target of Rs 48 and a stop loss of Rs 40.90 ET Now: What is your recommendation? Mitesh Thacker: Orchid Pharma is a 'BUY' call with a target of Rs 48 and a ... Economic Times, 1 week ago
DNA

Orchid Pharma advances 11%, receives EIR from USFDA

16:35 IST The drug major announced that it has received the Establishment inspection report (EIR) from USFDA based on the successful inspection closure for the API manufacturing facility located at Alathur, Kancheepuram District, India. The ...
 India Infoline2 weeks ago Orchid Pharma surges over 13% after receiving USFDA's inspection report  DNA2 weeks ago Orchid Pharma jumps over 13% on getting EIR report from USFDA  Business Standard2 weeks ago Orchid Pharma Jumps Over 13% On Positive Inspection Report  NDTV2 weeks ago
[x]  
India Infoline

Orchid Pharma shares surge 11% on successful inspection report from USFDA for TN facility

Orchid Pharma shares advanced as much as 13 per cent after it informed bourses that the company has received the Establishment Inspection Report (EIR) from US Food and Drug Administration (Reuters) Orchid Pharma shares advanced as much as 13 per ...
 Financial Express2 weeks ago Pharmaceutical Newsletter - April 11 to  India Infoline2 weeks ago Sun Pharma, Psyco Remedies settle trademark litigation and other top pharma news  India Infoline2 weeks ago Orchid receives FDA nod for Rasagiline generic formulation...  Bio Spectrum Asia2 weeks ago
[x]  
Business Line

Orchid Pharma, DLF among 12 stocks hogging limelight in Monday'strade

The Sensex recovered over 115 points in early session on Monday on fresh spell of buying in select bluechip stocks amid mixed Asian cues. At 11.10 am, Sensex was trading 13.16 points down at 24,660.68, while NSE Nifty was trading 1.15 points down at ...
 Yahoo! India2 weeks ago Stocks in focus: Bharti Airtel, Orchid Pharma, Sun Pharma, DLF, Rupa  Business Line2 weeks ago Orchid Pharma, DLF among 10 stocks that remained in focus in Monday's trade  Financial Express2 weeks ago
India Infoline

Orchid Pharma informs about company updates

A dedicated place to get a comprehensive economic update, Interactive tools and to voice your opinions. News pertaining to Markets, Corporates, Industry, Economy, Mutual Fund and Business RBI Policy Indicators, Exchange Rates and General ...
 Finalaya.com2 weeks ago Orchid Pharma receives EIR from US FDA for Kancheepuram facility  India Infoline2 weeks ago Orchid Pharma receives EIR for Tamil Nadu plant  MyIris2 weeks ago
[x]  
Money Control

Orchid Pharma gets final nod from USFDA for Parkinson's drug

CHENNAI: The shares of Chennai-based drugmaker Orchid Pharma Ltd have jumped over 13% in mid-day trade after the company announced its drug for Parkinson's Disease has been approved by the US Food and Drug Administration in what it says is a ...
 Economic Times1 month ago Orchid gets final nod from USFDA for Parkinson's drug  Money Control1 month ago
[x]  

Sun Pharmas Novartis deal could be a bright spot [tayyar.org (Lebanon)]

Sun Pharma's acquisition of 14 established prescription brands of Swiss drug maker Novartis in Japan will give it a head start in the $73 billion brand-conscious market but experts noted the company is likely to face challenges like periodic cuts in ...
 Pharmacy Choice3 weeks ago Sun Pharma's Novartis deal could be a bright spot  Economic Times4 weeks ago Sun Pharma’s Novartis deal could be a bright spot  Economic Times4 weeks ago

Pharmaceutical Newsletter - March 14 to

Top News Corex...Delhi High Court grants relief to Pfizer The Delhi High Court on Monday stayed a Government notification that had banned the manufacture and sale of Pfizer's popular cough syrup Corex, and also directed the Centre not to take ...
 India Infoline1 month ago

Sensex, Nifty off day's high; Lupin, HDFC, Sun Pharma fall 1-4%

14:00 Moneycontrol Bureau 2:44 pm Market Update: Equity benchmarks erased more than half of gains in afternoon trade. The Sensex rose 80.69 points to 24763.17 and the Nifty climbed 33.75 points to 7532.50. 2:35 pm Buzzing: Shares of Orchid ...
 Moneycontrol.com1 month ago Sensex, Nifty extend losses but Midcap, Smallcap outperform  Moneycontrol.com2 weeks ago
Livemint.com

Pharma stocks dive 20-55% this year after ban on combination drugs

While Marksans Pharma has fallen 47% in 2016 so far, Wockhardt posted a decline of 38% and Pfizer 29% Mumbai: The government ban on fixed dose combination (FDC) drugs has taken a toll on pharmaceuticals stocks, which saw a fall in the range of ...
 Livemint.com1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less